Key facts
- This page summarizes PERCEPTIVE ADVISORS LLC's Form 4 filing for LianBio (LIANY).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Feb 2024, 17:25.
PERCEPTIVE ADVISORS LLC - 15 Feb 2024 Form 4 Insider Report for LianBio (LIANY)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- LIANY
- Reported as of
- 15 Feb 2024
- Net transaction value
- -$3.36
- SEC form
- 4
- Accepted by SEC
- 20 Feb 2024, 17:25:28 UTC
- Prior SEC filing
- 05 Feb 2024
- Next SEC filing
- 21 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
PERCEPTIVE ADVISORS LLC filed Form 4 for LianBio (LIANY) on 20 Feb 2024.
Change
- Previous filing in this sequence was filed on 05 Feb 2024.
- Current net transaction value: -$3.36.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LIAN
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $91,476
- Shares
- +36,300
- Change %
- Price
- $2.52
- Shares after
- 36,300
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F1
LIAN
transaction
Ordinary Shares
Tax liability
- Transaction value
- $91,478
- Shares
- -19,218
- Change %
- -53%
- Price
- $4.76
- Shares after
- 17,082
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F1
LIAN
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $91,476
- Shares
- +36,300
- Change %
- Price
- $2.52
- Shares after
- 36,300
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F2
LIAN
transaction
Ordinary Shares
Tax liability
- Transaction value
- $91,478
- Shares
- -19,218
- Change %
- -53%
- Price
- $4.76
- Shares after
- 17,082
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F2
LIAN
holding
American Depository Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,728,491
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F3, F4
LIAN
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,368,895
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F4
LIAN
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 21,653,385
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F5
LIAN
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,330,675
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F6
LIAN
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,477,005
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F7
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LIAN
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -36,300
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 15 Feb 2024
- Ownership
- See Footnote
- Underlying class
- Ordinary Shares
- Underlying amount
- 36,300
- Exercise price
- $2.52
- Footnotes
- F1
LIAN
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -36,300
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 15 Feb 2024
- Ownership
- See Footnotes
- Underlying class
- Ordinary Shares
- Underlying amount
- 36,300
- Exercise price
- $2.52
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Represents securities held by Adam Stone. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the securities of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset.
Footnote F2
Represents securities held by Konstanin Poukalov. Mr. Poukalov is affiliated with the Advisor. The Advisor may be deemed to have an indirect pecuniary interest in the securities of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Poukalov's board service through a partial management fee offset.
Footnote F3
Each American Depositary Share represents one Ordinary Share of the Issuer.
Footnote F4
The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund"). The Advisor serves as the investment advisor to the Master Fund. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Footnote F5
The securities are directly held by LEV LB Holdings, LP ("LEV LB"). LEV LB Holdings GP, LLC ("LEV LB LLC") is the manager of LEV LB. Mr. Edelman is the sole member of LEV LB LLC. LEV LB LLC and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Footnote F6
The securities are directly held by Perceptive Xontogeny Venture Fund, LP ("Perceptive Xontogeny"). Perceptive Venture Advisors, LLC (the "Venture Advisor") serves as the investment advisor to Perceptive Xontogeny and is an affiliate of the Advisor. Joseph Edelman is the managing member of the Advisor. The Venture Advisor, the Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Footnote F7
The securities are directly held by C2 Life Sciences LLC ("C2 Life"). The Advisor serves as the investment advisor to C2 Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.